About
Huxley Medical bridges the gap between cardiology and sleep medicine through its flagship product, SANSA®—a revolutionary home sleep apnea testing patch that simultaneously captures ECG and nine channels of physiological data. Designed for busy clinical practices, SANSA® removes the friction of traditional diagnostic pathways by shipping directly to patients, who simply press a button to begin testing. Data is automatically uploaded via built-in cellular connectivity, requiring no Bluetooth or smartphone app. The cloud-native Huxley HUB™ platform manages the entire end-to-end workflow: physicians prescribe through the portal, Huxley ships the patch, and FDA-cleared AI algorithms auto-score results at 3% and 4% AHI thresholds for mild, moderate, and severe obstructive sleep apnea. Reports include SpO2, heart rate, respiratory effort, chest movement, ECG, body position, actigraphy, snoring, and sleep/wake staging—all delivered directly to the relevant specialists. Validated in the largest multi-site clinical trial of its kind against gold-standard polysomnography (PSG), SANSA® is purpose-built for cardiologists and sleep physicians seeking to expand diagnostic capacity without adding administrative burden. HIPAA-compliant encryption and real-time epoch-by-epoch review tools give clinicians full control over data interpretation. SANSA Express™ further eliminates inventory management and testing backlogs, making scalable, high-quality cardiosleep diagnostics accessible to practices of all sizes.
Key Features
- Simultaneous ECG & Sleep Apnea Testing: A single chest patch captures both cardiac rhythm (ECG) and full sleep apnea diagnostics in one study, bridging cardiology and sleep medicine.
- AI-Powered Auto-Scoring: FDA-cleared algorithms automatically score AHI at 3% and 4% thresholds across nine physiological data channels, reducing manual review time.
- App-Free Cellular Data Upload: Built-in cellular connectivity transmits patient data directly to the Huxley HUB™ with no Bluetooth pairing, smartphone app, or patient tech support required.
- Direct-to-Patient Test Delivery via SANSA Express™: Huxley ships the patch directly to patients after a physician order, eliminating scheduling backlogs, in-clinic setup, and inventory management.
- Cloud-Native Huxley HUB™ Management Platform: A HIPAA-compliant web portal with real-time re-scoring, epoch-by-epoch review, customizable report templates, and secure delivery of reports to relevant specialists.
Use Cases
- Cardiologists screening high-risk patients for comorbid sleep apnea and atrial fibrillation in a single at-home study.
- Sleep medicine practices expanding diagnostic capacity without increasing in-clinic appointments or device inventory.
- Primary care physicians ordering home sleep apnea tests for patients who cannot easily travel to a sleep lab.
- Hospital systems modernizing their cardiosleep referral pathways to reduce wait times and improve patient throughput.
- Clinical researchers conducting large-scale cardiosleep studies requiring validated, multi-channel physiological data collection.
Pros
- Eliminates Multiple Clinic Visits: Direct-to-patient shipping and a streamlined digital workflow remove the need for in-person setup appointments, reducing patient burden and practice overhead.
- FDA-Cleared & Clinically Validated: SANSA® is validated against gold-standard polysomnography in the largest multi-site clinical trial of its kind, giving clinicians confidence in diagnostic accuracy.
- Comprehensive 9-Channel Data: Captures SpO2, heart rate, respiratory effort, ECG, body position, actigraphy, snoring, and sleep/wake staging in a single study—far richer than standard home sleep tests.
- Scalable Without Added Administrative Burden: The hands-free, app-free workflow and 24/7 live support enable practices to scale diagnostic capacity without hiring additional staff.
Cons
- Requires Physician Prescription: Patients cannot self-order SANSA®; a physician must determine eligibility and place the order through the Huxley HUB™, adding a prerequisite step.
- Pricing Not Publicly Available: As a medical device service, pricing is not disclosed on the website and requires direct contact with Huxley, making cost comparison difficult for smaller practices.
- Limited to Cardiosleep Diagnostics: SANSA® is purpose-built for ECG and sleep apnea testing and does not cover broader clinical monitoring or other diagnostic modalities.
Frequently Asked Questions
SANSA® is an FDA-cleared wireless biosensor patch that patients wear on their chest during sleep. It captures nine channels of physiological data—including ECG and respiratory metrics—and automatically uploads the data via built-in cellular connectivity to the Huxley HUB™, where AI algorithms generate a diagnostic report for physician review.
Yes. SANSA® is FDA-cleared for home sleep apnea testing and has been validated against gold-standard polysomnography (PSG) in the largest multi-site clinical trial of its kind.
No. SANSA® has built-in cellular connectivity that automatically transmits data once the test is complete. No Bluetooth pairing, smartphone, or app download is required from the patient.
SANSA® records nine channels: AHI (sAHI) at 3% and 4% desaturation, Oximetry/SpO2, Heart Rate, Respiratory Effort, Chest Movement, ECG, Body Position, Actigraphy, Snoring, and Sleep/Wake Staging.
With SANSA Express™, the physician assesses the patient and prescribes the test through Huxley HUB™. Huxley then ships the patch directly to the patient, who tests at home and returns the device via a pre-paid label. The AI-generated report is automatically delivered to the physician on the HUB™, with no in-clinic device management needed.